From the Departments of Human Anatomy and Histology (D.B., T.B.S.) and of
Preclinical and Clinical Pharmacology (P.F., M.G.B., E.M.), University of
Florence; the Prosperius Institute (M.B.), Florence, Italy; and the William
Harvey Research Institute, London, UK (C.T.).
Correspondence to Prof Tatiana Bani Sacchi, Dipartimento di Anatomia Umana e Istologia, Sezione di Istologia, Viale G. Pieraccini 6, I-50139 Firenze, Italy. E-mail histology{at}cesit1.unifi.it
AbstractThe peptide hormone relaxin
(RLX) has been shown to elicit a powerful vasodilatory response in
several target organs. This response is mediated by the stimulation of
intrinsic nitric oxide (NO) generation. The present study was
designed to clarify whether RLX directly promotes the relaxation of
vascular smooth muscle cells through stimulation of NO generation.
Vascular smooth muscle cells from bovine aortas were incubated with RLX
at concentrations ranging from 1 nmol/L to 1 µmol/L. The
expression and activity of NO synthase, production of NO, and
the intracellular levels of cGMP and Ca2+ were determined.
The cell morphology and signal transduction mechanisms of these bovine
aortic smooth muscle cells in response to RLX were also studied. RLX
stimulated the expression of immunoreactive inducible NO synthase and
increased significantly and in a concentration-related fashion
inducible NO synthase activity, NO generation, and intracellular cGMP
levels. Concurrently, RLX significantly decreased cytosolic
Ca2+ concentrations and caused changes in cell shape and
the actin cytoskeleton that were consistent with cell
relaxation. The signal transduction mechanisms leading to the enhanced
expression of inducible NO synthase protein and activity caused by RLX
involve the activation of tyrosine kinase,
phosphatidylcholinephospholipase C, and the transcription factor
nuclear factor-
© 1998 American Heart Association, Inc.
Scientific Contributions
Relaxin Activates the L-ArginineNitric Oxide Pathway in Vascular Smooth Muscle Cells in Culture
B, similar to bacterial endotoxins and
proinflammatory cytokines. This study suggests that RLX is an
endogenous agent capable of regulating vascular tone by
activation of the L-arginineNO pathway in vascular smooth
muscle cells.
Key Words: muscle, smooth, vascular relaxin nitric oxide
This article has been cited by other articles:
![]() |
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Figueiredo, A. L. Mui, C. C. Nelson, and M. E. Cox Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism J. Biol. Chem., February 10, 2006; 281(6): 3030 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Nguyen and C. W. Dessauer Relaxin Stimulates Protein Kinase C {zeta} Translocation: Requirement for Cyclic Adenosine 3',5'-Monophosphate Production Mol. Endocrinol., April 1, 2005; 19(4): 1012 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Baccari, D. Bani, M. Bigazzi, and F. Calamai Influence of Relaxin on the Neurally Induced Relaxant Responses of the Mouse Gastric Fundus Biol Reprod, October 1, 2004; 71(4): 1325 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Conrad and J. Novak Emerging role of relaxin in renal and cardiovascular function Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Quattrone, L. Chiappini, G. Scapagnini, B. Bigazzi, and D. Bani Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture Mol. Hum. Reprod., May 1, 2004; 10(5): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. D. Sherwood Relaxin's Physiological Roles and Other Diverse Actions Endocr. Rev., April 1, 2004; 25(2): 205 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Masini, S. Nistri, A. Vannacci, T. B. Sacchi, A. Novelli, and D. Bani Relaxin Inhibits the Activation of Human Neutrophils: Involvement of the Nitric Oxide Pathway Endocrinology, March 1, 2004; 145(3): 1106 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Baccari, S. Nistri, S. Quattrone, M. Bigazzi, T. Bani Sacchi, F. Calamai, and D. Bani Depression by Relaxin of Neurally Induced Contractile Responses in the Mouse Gastric Fundus Biol Reprod, January 1, 2004; 70(1): 222 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Nguyen, L. Yang, B. M. Sanborn, and C. W. Dessauer Phosphoinositide 3-Kinase Activity Is Required for Biphasic Stimulation of Cyclic Adenosine 3',5'-Monophosphate by Relaxin Mol. Endocrinol., June 1, 2003; 17(6): 1075 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fisher, M. MacLean, I. Morecroft, A. Seed, F. Johnston, C. Hillier, and J. McMurray Is the Pregnancy Hormone Relaxin Also a Vasodilator Peptide Secreted by the Heart? Circulation, July 16, 2002; 106(3): 292 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bani, M. Caterina Baccari, S. Quattrone, S. Nistri, F. Calamai, M. Bigazzi, and T. Bani Sacchi Relaxin Depresses Small Bowel Motility Through a Nitric Oxide-Mediated Mechanism. Studies in Mice Biol Reprod, March 1, 2002; 66(3): 778 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kristiansson and J.X. Wang Reproductive hormones and blood pressure during pregnancy Hum. Reprod., January 1, 2001; 16(1): 13 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. D. Sherwood, L. M. Olson, S. Zhao, and H. R. Little Inhibition of Nitric Oxide Synthase Activity Diminishes the Acute Effects of Relaxin on Growth, But Not Softening, of the Cervix in the Rat Endocrinology, July 1, 2000; 141(7): 2458 - 2464. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bani, M. C. Baccari, S. Nistri, F. Calamai, M. Bigazzi, and T. B. Sacchi Relaxin Up-Regulates the Nitric Oxide Biosynthetic Pathway in the Mouse Uterus: Involvement in the Inhibition of Myometrial Contractility Endocrinology, October 1, 1999; 140(10): 4434 - 4441. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |